Bone Biopsy Market by Type, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Feb 2023 Pages: 155 SKU: IRTNTR71463

Bone Biopsy Market Forecast 2023-2027

The bone biopsy market is estimated to increase by USD 76.77 million, growing at a CAGR of 7.74% between 2022 and 2027. The growth of the market depends on several factors, including the growing number of diagnostic centers, the rising prevalence of cancer, and the increasing preference for minimally invasive biopsies.

What will be the size of the Bone Biopsy Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

The market share growth of the needle biopsy segment will be significant during the forecast period. Needle biopsies are majorly performed as minimally invasive biopsy procedures for the better assessment of bone cancer within an outpatient setting. The need for highly skilled operators to handle imaging modalities such as CT scans and the lower technical complexities involved in this method are driving the demand for needles for the extraction of normal bone tissues for biopsy.

Get a glance at the market contribution of various segments Request a PDF Sample

The needle biopsy segment was valued at USD 85.44 million in 2017 and continued to grow until 2021.  Core needle biopsy (CNB) and fine-needle aspiration biopsy (FNAB) are the two major types of needle biopsies that are performed in the presence of a palpable mass or a non-palpable abnormal finding. A needle biopsy is considered the gold standard procedure for bone biopsies. Core needle biopsy is a quick process as it does not involve surgery. Owing to these factors, needle bone biopsies are accepted by physicians as standard biopsy procedures.

Market Dynamic

The rising prevalence of cancer is notably driving the market growth, although factors such as the risk of infections associated with the use of biopsy needles may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

The rising prevalence of cancer is notably driving market growth. Cancer is becoming a major health concern as it is one of the most common chronic diseases worldwide and is responsible for rising mortality rates for people worldwide. Bone cancer is one of the most common types of cancer. 

Approximately 70% of cancer patients are suitable for biopsy. End-users are increasingly preferring needle biopsy over open biopsy, as it is non-invasive and can detect the presence of various cancers more effectively using the individual blood sample. It provides vital information to the oncologist to select the appropriate treatment methods, including the type of surgery, radiotherapy, and drugs required for the treatment. Thus, the increasing incidence of cancers will subsequently increase the diagnosis using the biopsy method, which is expected to drive the growth of the market during the forecast period.

Significant Trend

The growing demand for MRI and ultrasound-guided procedures is the key trend in the market. MRI has witnessed a rapid improvement in the management of bone cancer in the last decade. In addition, the MRI technique can provide functional information through magnetic resonance spectroscopy, dynamic contrast-enhanced (DCE), and diffusion-weighted imaging (DWI). The multi-parametric features of MRI have the potential to exclude significant cancer in most cases. Performing an MRI reduces the invasiveness of the treatment procedure by limiting the number of cores needed to make an accurate diagnosis. 

Evolving techniques in ultrasound, such as contrast-enhanced ultrasound (CEUS) and real-time ultrasound elastography (RTE), are being tested to improve and detect the yield by allowing targeted biopsies. Therefore, the rise in demand for bone cancer screening with image guidance is estimated to propel the growth of the market during the forecast market.

Major Challenge

The risk of infections associated with the use of biopsy needles is the major challenge impeding the market growth. In several reported cases, bone needle biopsies have been known to cause significant complications among patients such as bleeding, infection, pain, fever, and transient urinary problems. In a few cases, individuals would also require hospitalization due to these complications. In addition, faulty execution of biopsies can cause damage to nearby tissues or organs, as well as skin numbness around the biopsy site. A range of complications that can occur after a bone needle biopsy include bacteremia accompanied by sepsis, asymptomatic bacteriuria, and urinary tract infection.

According to multiple research studies, the risk of post-biopsy infection for a man who has undergone more than two previous biopsies is about 2%, and then rises correspondingly to 5%, 10%, and 15% in individuals who underwent bone biopsies three, four, or more than four biopsies, respectively. Thus, there is a growing need among the end-users the adoption of liquid biopsy tests, owing to complications associated with needle biopsies. Therefore it is expected to obstruct the growth of the market during the forecast period.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Bone Biopsy Market companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Tsunami Medical Srl -  The company offers bone biopsy kits with a coaxial design as its key offering which allows biopsy collection of the core sample within the vertebral body. Under this segment, the company is one of the leaders in spine technology innovation which focuses on 3D printed solutions for spine surgery and diagnostic invasive procedures.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Becton Dickinson and Co.
  • BIOPSYBELL Srl
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Kimal Group
  • Laurane Medical LLC
  • Meditech Devices Pvt. Ltd.
  • Medtronic Plc
  • Merit Medical Systems Inc.
  • Moller Medical GmbH
  • Remington Medical
  • SOMATEX Medical Technologies GmbH
  • Teleflex Inc.
  • Zamar Care
  • B. Braun SE
  • Stryker Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market in North America will grow at a moderate rate during the forecast period. North America has been witnessing an increase in the adoption of various advanced technologies over the past few years. The majority of the market growth in this region is driven by high technology adoption in the healthcare sector, increasing healthcare expenditure, and the rising prevalence of bone cancer. In addition, the growing presence of companies that manufacture systems and increasing technological advances in biopsy techniques are driving the growth of the market in North America.

Market Analyst Overview

The Market addresses the diagnosis and treatment of bone disorders and abnormalities, serving as a crucial diagnostic tool to identify the cause of pain and detect conditions such as bone tumors, bone cancers, lymphoma, and leukemia disease. With stringent regulatory policies overseen by institutions like the Center for Devices and Radiological Health, medical devices utilized procedures adhere to strict quality standards. Common techniques include CT-guided bone marrow biopsy, performed in hospitals, clinics, and surgical centers. As advancements in technology and medical practices continue, the market plays a pivotal role in improving diagnostic accuracy and facilitating targeted treatment strategies for various bone-related ailments.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Million, 2017 - 2027)
    • Needle biopsy
    • Open biopsy
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospitals
    • Diagnostic centers
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Market Scope

Report Coverage

Details

Page number

155

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.74%

Market growth 2023-2027

USD 76.77 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.92

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Becton Dickinson and Co., BIOPSYBELL Srl, Cardinal Health Inc., Cook Group Inc., Kimal Group, Laurane Medical LLC, Meditech Devices Pvt. Ltd., Medtronic Plc, Merit Medical Systems Inc., Moller Medical GmbH, Remington Medical, SOMATEX Medical Technologies GmbH, Teleflex Inc., Tsunami Medical Srl, Zamar Care, B. Braun SE, and Stryker Corp.

Market dynamics

Parent market analysis, Market forecasting, market growth and trends, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market research report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global bone biopsy market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global bone biopsy market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Needle biopsy - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Needle biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Needle biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Needle biopsy - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Needle biopsy - Year-over-year growth 2022-2027 (%)
    • 6.4 Open biopsy - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Open biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Open biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Open biopsy - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Open biopsy - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 7.4 Diagnostic centers - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by End-user
      • Exhibit 56: Market opportunity by End-user ($ million)
      • Exhibit 57: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 France - Market size and forecast 2022-2027
      • Exhibit 91: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 B. Braun SE
              • Exhibit 107: B. Braun SE - Overview
              • Exhibit 108: B. Braun SE - Business segments
              • Exhibit 109: B. Braun SE - Key news
              • Exhibit 110: B. Braun SE - Key offerings
              • Exhibit 111: B. Braun SE - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 112: Becton Dickinson and Co. - Overview
              • Exhibit 113: Becton Dickinson and Co. - Business segments
              • Exhibit 114: Becton Dickinson and Co. - Key news
              • Exhibit 115: Becton Dickinson and Co. - Key offerings
              • Exhibit 116: Becton Dickinson and Co. - Segment focus
            • 12.5 BIOPSYBELL Srl
              • Exhibit 117: BIOPSYBELL Srl - Overview
              • Exhibit 118: BIOPSYBELL Srl - Product / Service
              • Exhibit 119: BIOPSYBELL Srl - Key offerings
            • 12.6 Cardinal Health Inc.
              • Exhibit 120: Cardinal Health Inc. - Overview
              • Exhibit 121: Cardinal Health Inc. - Business segments
              • Exhibit 122: Cardinal Health Inc. - Key news
              • Exhibit 123: Cardinal Health Inc. - Key offerings
              • Exhibit 124: Cardinal Health Inc. - Segment focus
            • 12.7 Cook Group Inc.
              • Exhibit 125: Cook Group Inc. - Overview
              • Exhibit 126: Cook Group Inc. - Product / Service
              • Exhibit 127: Cook Group Inc. - Key offerings
            • 12.8 Kimal Group
              • Exhibit 128: Kimal Group - Overview
              • Exhibit 129: Kimal Group - Product / Service
              • Exhibit 130: Kimal Group - Key offerings
            • 12.9 Laurane Medical LLC
              • Exhibit 131: Laurane Medical LLC - Overview
              • Exhibit 132: Laurane Medical LLC - Product / Service
              • Exhibit 133: Laurane Medical LLC - Key offerings
            • 12.10 Meditech Devices Pvt. Ltd.
              • Exhibit 134: Meditech Devices Pvt. Ltd. - Overview
              • Exhibit 135: Meditech Devices Pvt. Ltd. - Product / Service
              • Exhibit 136: Meditech Devices Pvt. Ltd. - Key offerings
            • 12.11 Medtronic Plc
              • Exhibit 137: Medtronic Plc - Overview
              • Exhibit 138: Medtronic Plc - Business segments
              • Exhibit 139: Medtronic Plc - Key news
              • Exhibit 140: Medtronic Plc - Key offerings
              • Exhibit 141: Medtronic Plc - Segment focus
            • 12.12 Merit Medical Systems Inc.
              • Exhibit 142: Merit Medical Systems Inc. - Overview
              • Exhibit 143: Merit Medical Systems Inc. - Business segments
              • Exhibit 144: Merit Medical Systems Inc. - Key offerings
              • Exhibit 145: Merit Medical Systems Inc. - Segment focus
            • 12.13 Remington Medical
              • Exhibit 146: Remington Medical - Overview
              • Exhibit 147: Remington Medical - Product / Service
              • Exhibit 148: Remington Medical - Key offerings
            • 12.14 SOMATEX Medical Technologies GmbH
              • Exhibit 149: SOMATEX Medical Technologies GmbH - Overview
              • Exhibit 150: SOMATEX Medical Technologies GmbH - Product / Service
              • Exhibit 151: SOMATEX Medical Technologies GmbH - Key offerings
            • 12.15 Stryker Corp.
              • Exhibit 152: Stryker Corp. - Overview
              • Exhibit 153: Stryker Corp. - Business segments
              • Exhibit 154: Stryker Corp. - Key news
              • Exhibit 155: Stryker Corp. - Key offerings
              • Exhibit 156: Stryker Corp. - Segment focus
            • 12.16 Tsunami Medical Srl
              • Exhibit 157: Tsunami Medical Srl - Overview
              • Exhibit 158: Tsunami Medical Srl - Product / Service
              • Exhibit 159: Tsunami Medical Srl - Key offerings
            • 12.17 Zamar Care
              • Exhibit 160: Zamar Care - Overview
              • Exhibit 161: Zamar Care - Product / Service
              • Exhibit 162: Zamar Care - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 163: Inclusions checklist
                • Exhibit 164: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 165: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 166: Research methodology
                • Exhibit 167: Validation techniques employed for market sizing
                • Exhibit 168: Information sources
              • 13.5 List of abbreviations
                • Exhibit 169: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              bone biopsy market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis